Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Couto Alves, M. R. Jarvelin, A. Walley (London, United Kingdom). LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA. Eur Respir J 2014; 44: Suppl. 58, 4774

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: THE FATE OF INHALED DRUG: CORTICOSTEROID PARTICLE SIZE EFFECTS IN ASTHMA Source: Annual Congress 2013 –New physiologic boundaries Year: 2013 LATE-BREAKING ABSTRACT: PERSISTENTLY HIGH EXHALED NITRIC OXIDE AND LUNG FUNCTION DECLINE IN PATIENTS WITH CONTROLLED ASTHMA AT BASELINE Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 CARDIOVASCULAR RISK (CVR) AND EFFECTS ON THE QUALITY OF LIFE AFTER A PHYSICAL REHABILITATION PROGRAM ON COPD PATIENTS BASED ON THEIR PHENOTYPE: EXACERBATOR (E) OR NON-EXACERBATOR (NE) Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 LATE-BREAKING ABSTRACT: GENDER DIFFERENCES IN ASTHMATIC CHILDREN Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES. Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY. Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe Year: 2020 SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES. Source: Eur Respir J 2007; 29: 614 Year: 2007 INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation Year: 2020 Late Breaking Abstract - PULMONARY REHABILITATION IN POST - COVID SUBJECTS WITH MODERATE LUNG RESTRICTION, A CASE SERIES. Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021 THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 BENEFITS OF EARLY DIAGNOSIS AND TREATMENT OF OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE: SASS (Sleep Apnea in Stroke patients Study) Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 WHAT TOOLS AND RESOURCES DO PULMONARY REHABILITATION TEAMS USE TO DELIVER EDUCATION? Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 LUNG ADENOCARCINOMA: CLINICAL CHARACTERISTICS, MOLECULAR STUDY, DIAGNOSIS AND TREATMENT. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021